CYTOMETRIC ASSESSMENT OF THE CELLULAR COMPARTMENT OF THE IMMUNE SYSTEM IN PATIENTS AFTER END-TO-END KERATOPLASTY
- Authors: Kuznetzov A.A.1, Bystrov A.M.1,2, Davydova E.V.1,2, Chereshneva M.V.3, Gavrilova T.V.4
-
Affiliations:
- Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russia
- Federal State Budgetary Educational Institution of Higher Education "South-Ural State Medical University" of the Ministry of Healthcare of the Russian Federation, Chelyabinsk, Russia
- Institute of Immunology and Physiology UrB RAS, Ekaterinburg, Russia
- Federal State Budgetary Educational Institution of Higher Education "Perm State Medical University named after Academician E.A. Wagner" of the Ministry of Healthcare of the Russian Federation, Perm, Russia
- Section: Immunological readings in Chelyabinsk
- Submitted: 18.03.2025
- Accepted: 25.05.2025
- URL: https://rusimmun.ru/jour/article/view/17113
- DOI: https://doi.org/10.46235/1028-7221-17113-CAO
- ID: 17113
Cite item
Full Text
Abstract
Abstract
The graft rejection reaction, especially in patients from the "high risk" group, is a complex immunological process that remains an urgent problem in ophthalmology. The cornea, despite its immunological privilege, loses its protective barriers under certain conditions (vascularization, inflammation), which leads to the development of an immune response against the transplant. The key mechanisms of rejection are activation of T-lymphocytes (CD4+ and CD8+), as well as an imbalance between effector and regulatory immune cells. Modern methods of immunological monitoring, including analysis of T-cell populations, make it possible to detect signs of rejection in a timely manner and adjust therapy to improve long-term transplant results. The aim of the study was to conduct a comparative cytometric analysis of the population and subpopulation composition of blood lymphocytes in patients after end-to-end keratoplasty.
Materials and methods. The study involved 46 patients who underwent end-to-end keratoplasty, who were divided into two subgroups: those with transplant rejection (n=25) and those with successful engraftment (n=21), as well as a control group of 21 healthy volunteers. The immunological analysis included venous blood sampling and quantitative determination of lymphocyte subpopulations by flow cytometry using a Navios cytofluorimeter (Beckman Coulter, USA) and CD45+ and CD46+ markers. Key populations of lymphocytes, including T helper cells, cytotoxic T lymphocytes, NK cells, B lymphocytes, and activated T cells, were studied to identify differences in the immune status of patients. Results. Comparative cytometric analysis of the population and subpopulation composition of peripheral blood lymphocytes in "high-risk" patients with graft rejection showed a number of significant changes in the form of an increase in the total number of T-lymphocytes, T-helper cells, T-cytotoxic, T-lymphocytes with markers of early and late activation, which indicates the key role of T-cell the role of immunity in the mechanisms of development of late cellular rejection reactions. Conclusion. 1. The data obtained demonstrate the involvement of systemic cellular mechanisms in the implementation of the rejection reaction of the native corneal allograft and dictate the need for a more detailed study of the T-cell response of the immune system. 2. Cytometric assessment of subpopulations of immunocytes makes it possible to identify early signs of immune activation associated with rejection and opens up new opportunities for the development of personalized and effective treatment strategies aimed at improving transplant outcomes.
Keywords
About the authors
Andrey Aleksandrovich Kuznetzov
Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russia
Email: cheloptic@mail.ru
Ph.D. of Medical Sciences, Head of the Ophthalmology Center
Russian Federation, Vorovskiy str., 70, Chelyabinsk, 454048, RussiaAleksey Mikhaylovich Bystrov
Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russia;Federal State Budgetary Educational Institution of Higher Education "South-Ural State Medical University" of the Ministry of Healthcare of the Russian Federation, Chelyabinsk, Russia
Email: highvision@bk.ru
ORCID iD: 0009-0008-0712-4491
SPIN-code: 1359-5140
Researcher of Ophthalmology Department ;
Senior Laboratory Assistant at the Department of Medical Rehabilitation and Sports Medicine
Russian Federation, Vorovskiy str., 70, Chelyabinsk, 454048, Russia; Vorovskiy str., 64, Chelyabinsk, 454141, RussiaEvgeniya Valerevna Davydova
Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russia;Federal State Budgetary Educational Institution of Higher Education "South-Ural State Medical University" of the Ministry of Healthcare of the Russian Federation, Chelyabinsk, Russia
Email: davidova-ev.med@yandex.ru
Doctor of Medical Sciences, Associate Professor, Head of the Department of Early Medical Rehabilitation of the Chelyabinsk Regional Clinical Hospital, Professor of the Department of Medical Rehabilitation and Sports Medicine
Russian Federation, Vorovskiy str., 70, Chelyabinsk, 454048, Russia; Vorovskiy str., 64, Chelyabinsk, 454141, RussiaMargarita Vladimirovna Chereshneva
Institute of Immunology and Physiology UrB RAS, Ekaterinburg, Russia
Email: mchereshneva@mail.ru
Doctor of Medical Sciences, Professor, Honored Scientist of the Russian Federation, Chief Researcher at the Laboratory of Immunophysiology and Immunopharmacology
Russian Federation, Pervomayskaya St., 106, Yekaterinburg, 620078, RussiaTatyana Valerevna Gavrilova
Federal State Budgetary Educational Institution of Higher Education "Perm State Medical University named after Academician E.A. Wagner" of the Ministry of Healthcare of the Russian Federation, Perm, Russia
Author for correspondence.
Email: gavrilova.tv@mail.ru
Doctor of Medical Sciences, Professor, Corresponding Member of the Russian Academy of Sciences, Head of the Department of Ophthalmology
Russian Federation, Petropavlovsk Street,26, Perm, 614990, Perm RegionReferences
- Аветисов С.Э., Егоров Е.А., Мошетова Л.К. Национальное руководство по офтальмологии. В кн.: Мороз З.И. Кератопластика и кератопротезирование. – М.: Гэотар-Медиа, 2008. – С. 472-474. Avetisov S.E., Egorov E.A., Moshetova L.K. National Guidelines for Ophthalmology. In: Moroz Z.I. Keratoplasty and keratoprosthetics. Moscow: Geotar-Media, 2008, pp. 472-474 ISBN 978-5-9704-5125-0
- URL: https://www.rosmedlib.ru/book/ISBN9785970451250.html
- Зурочка А.В., Хайдуков С.В., Кудрявцев И.В., Черешнев В.А. Проточная цитометрия в биомедицинских исследованиях. - Екатеринбург: РИО УрО РАН, 2018. - 720 с. Zurochka A.V., Khaidukov S.V., Kudryavtsev I.V., Chereshnev V.A. Flow cytometry in biomedical research. Ekaterinburg: RIO, Ural Branch of the Russian Academy of Sciences, 2018. 720 p. ISBN 978-5-7691-2497-6.
- Alio J.L., Montesel A., El Sayyad F., Barraquer R.I., Arnalich-Montiel F., Del Barrio J.L.A. Corneal graft failure: an update. British Journal of Ophthalmology, 2021, Vol. 105, no. 8, pp. 1049-1058. ISSN : 1468-2079 [doi: 10.1136/bjophthalmol-2020-316705]
- Avunduk A.M., Avunduk M.C., Tekelioğlu Y., Kapıcıoğlu Z. CD4+ T cell/CD8+ T cell ratio in the anterior chamber of the eye after penetrating injury and its comparison with normal aqueous samples. Japanese Journal of Ophthalmology, 1998, Vol. 42, no. 3, pp. 204-207 ISSN: 0021-5155 [doi: 10.1016/s0021-5155(97)00142-1]
- Boisgéraul F., Liu Y., Anosova N., Ehrlich E., Dana M.R., Benichou G. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation. The Journal of Immunology, 2001, Vol. 167, no. 4, pp. 1891-1899. ISSN 0022-1767 [doi: 10.4049/jimmunol.167.4.1891]
- Chi H., Wei C., Ma L., Yu Y., Zhang T., Shi W. The ocular immunological alterations in the process of high-risk corneal transplantation rejection. Experimental Eye Research, 2024, Vol. 245, pp. 109971 ISSN : 1096-0007 [doi: 10.1016/j.exer.2024.109971]
- Maharana P.K., Mandal S., Kaweri L., Sahay P., Lata S., Asif M.I., Sharma N. Immunopathogenesis of corneal graft rejection. Indian Journal of Ophthalmology, 2023, Vol. 71, no. 5, pp. 1733-1738. ISSN 0301-4738 [doi: 10.4103/IJO.IJO_2866_22]
- Mandal S., Maharana P.K., Kaweri L., Asif M.I., Nagpal R., Sharma N. Management and prevention of corneal graft rejection. Indian Journal of Ophthalmology, 2023, Vol. 71, no. 9, pp. 3149-3159. ISSN 0301-4738 [doi: 10.4103/IJO.IJO_228_23]
- Owen D.L., Mahmud S.A., Vang K.B., Kelly R.M., Blazar B.R., Smith K.A., Farrar M.A. Identification of cellular sources of IL-2 needed for regulatory T cell development and homeostasis. The Journal of Immunology, 2018, Vol. 200, no. 12, pp. 3926-3933 ISSN 0022-1767 [doi: 10.4049/jimmunol.1800097]
- Sakowska J., Glasner P., Dukat-Mazurek A., Rydz A., Zieliński M., Pellowska I., Trzonkowski P. Local T cell infiltrates are predominantly associated with corneal allograft rejection. Transplant Immunology, 2023, Vol. 79, pp. 101852 ISSN : 1878-5492 [doi: 10.1016/j.trim.2023.101852]
- Scarabosio A., Surico P.L., Tereshenko V., Singh R.B., Salati C., Spadea L., Zeppieri M. Whole-eye transplantation: Current challenges and future perspectives. World Journal of Transplantation, 2024, Vol. 14, no. 2, pp. 95009 ISSN : 2220-3230 [doi: 10.5500/wjt.v14.i2.95009]
- Vabres B., Pleyer U., Hjortdal J., Murphy C.C., Armitage W.J., Imrie L., Degauque N. Corneal Graft Rejection: Is it Reflected in Peripheral Immune Cells? Results of a Prospective Multicenter Study (VISICORT). Transplantation, 2025, pp. 10-1097 ISSN: 1534-6080 [doi: 10.1097/TP.0000000000005280]
- Völker-Dieben H.J., Claas F.H., Schreuder G.M.T., Schipper R.F., Pels E., Persijn G.G., D’Amaro J. Beneficial effect of HLA-DR matching on the survival of corneal Allografts. Transplantation, 2000, Vol. 70, no. 4, pp. 640-648 ISSN: 1534-6080 [doi: 10.1097/00007890-200008270-00018]
- Yin J. Advances in corneal graft rejection. Current Opinion in Ophthalmology, 2021, Vol. 32, no. 4, pp. 331-337 ISSN: 1531-7021 [doi: 10.1097/ICU.0000000000000767]
- Zhu J., Inomata T., Di Zazzo A., Kitazawa K., Okumura Y., Coassin M., Murakami A. Role of immune cell diversity and heterogeneity in corneal graft survival: A systematic review and meta-analysis. Journal of Clinical Medicine, 2021, Vol. 10, no. 20, pp. 4667 ISSN: 2077-0383 [doi: 10.3390/jcm10204667]
Supplementary files
